Release Date: 26/02/16 09:03 Summary: Appendix 4D & Financial Statements for Half Year 2016 Price Sensitive: Yes Download Document 862.28KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status